Instem Interact 2026 – A Resounding Success
Instem Team
Turning Insight into Innovation in Preclinical R&D
Regulatory Submission Blog
What the FDA Webcast Revealed About SEND (and Why It Matters)
Marc Ellison
“For the first time, the FDA openly acknowledged that they are rejecting some SEND datasets because the quality isn’t good enough. No ambiguity. Just a clear statement that quality matters, and that poor SEND has...
White Paper: Preparing Your Team for SEND 4.0
Instem Team
SEND 4.0 introduces one of the most significant updates to nonclinical data standards, expanding scientific coverage and modernizing core structures across the SEND ecosystem. This white paper outlines the key changes such as new domains,...
The Journey of a Molecule – IND Package Preparation
Instem Team
Complete, Compliant, and SEND‑Ready Submissions for Regulatory Success
The Journey of a Molecule – Toxicology
Instem Team
Accelerating Preclinical Safety with Connected Data and Predictive Insights
Stay up to Date
Get expert tips, industry news, and fresh content delivered to your inbox.
